was a total lack of bone and retention of the partially of membranous bones, and delayed ossification of cracalcified cartilagenous skeleton. Both membranous nial bones, causing open anterior and posterior fontabones of the skull and endochondral bone in the rest nelles, smaller parietal and interparietal cranial bones, of the skeleton were absent. The skull was a thin layer and multiple Wormian bones (small bones in the suof fibrous connective tissue, the tibiae contained only tures). These are typical features of a human mutation calcified cartilage, where bone is usually formed at this called cleidocranial dysplasia syndrome (CCD; Jensen, age. Histochemical analysis showed absence of osteo-1990) . Most interestingly, an identical syndrome had blastic cells and paucity and small size of osteoclasts, been produced in mice by gamma irradiation almost 20 the hematopoietically derived cells that normally remove years ago (Selby and Selby, 1978) and was recognized calcified cartilage and bone.
10 years ago to be the mouse equivalent of the autosoNorthern blot analysis of RNA extracted from bone in mal dominant human CCD syndrome (Sillence et al., homozygous Cbfa1 Ϫ/Ϫ mice confirmed the extremely 1987). Genetic analysis of the mice heterozygous for the low expression of genes associated with the osteoblas-CCD mutation in a C57BL/10 background crossed with tic phenotype: alkaline phosphatase, osteopontin, and C3H, DBA/2J, and M. castaneus inbred strains, identiosteocalcin. Localization of Cbfa1 during development fied the mutation on chromosome 17 and, using DNA by in situ hybridization documented its presence in remarkers, pointed to a disruption in the Cbfa1 gene. gions destined for bone development. At gestational Thus, in addition to corroborating independently the day 18.5, it was strongly expressed in osteoblasts and, essential role of Cbfa1 as a putative transcription factor at lower levels, in thymus, testes, and liver, but no dein osteoblast differentiation that cannot be compenfects in these organs were reported. Dilated blood vessated by another factor, these findings strongly implisels and mineral deposits were observed in the vascular cated this gene in CCD. They also suggested haplotype wall of the placenta, where no Cbfa1 mRNA was deinsufficiency for membranous but not endochondral tected. RT-PCR analysis of RNA from calvaria-derived ossification, which explains the autosomal pattern of cells, the skeleton, or skin, at gestational day 18.5 inheritance. The findings also drew attention to a strong (d18.5), showed no differences between wild type and component of intramembraneous bone in clavicle develhomozygous Cbfa1 Ϫ/Ϫ in the expression of osteogenic opment. growth factors TGF␤s, BMPs, IGFs and their receptors, Cleidocranial Dysplasia (CCD) or in MCSF, required for osteoclast formation, consis-
The human CCD syndrome (Jensen, 1990) , an autosomal tent with a downstream defect.
dominant disorder with all the features described above Indeed, rhBMP-2 up-regulation of the expression of in the Cbfa1 ϩ/Ϫ mice, plus supernumerary teeth, was genes associated with the osteoblastic phenotype, alkamapped to chromosome 6p21, where CBFA1 was localline phosphatase, and osteocalcin was significantly ized (Mundlos et al., 1995) . Aware of the information reduced in calvaria-derived cells from Cbfa1 Ϫ/Ϫ d18.5 generated by Otto et al. (1997) in mice, Mundlos et al. embryos. Similarly, the genes expressed in bone, osteo-(1997 [this issue of Cell]) proceeded to examine whether calcin, and osteopontin, estimated by in situ hybridiza-CBFA1 is the culprit gene for CCD in humans. Sixty-two tion, were suppressed in Cbfa1 Ϫ/Ϫ mice. There was no individuals, including 39 affected members, were tested major problem in hematopoiesis, except for an increase for linkage to the 6p locus and all had a positive lod in the number of nucleated cells in the circulation, attribscore. CBFA1 was one of the genes identified within the uted to extramedullary hematopoiesis, caused by the contig. Large deletions that included the CBFA1 locus lack of a normal marrow cavity.
were identified in three unrelated CCD patients. Analysis In a similar study, Otto et al. (1997 [this issue of Cell]) of CCD patients without chromosomal translocation independently deleted the Cbfa1 gene in mice and had found that three unrelated patients showed deletions identical findings in homozygous mutants: complete abincluding the CBFA1 region and four additional families sence of bone, smaller size, and neonatal death due to had insertions, deletions, or mutations that inactivated respiratory failure. Using a 7 kb genomic sequence and one allele or disrupted the runt domain of CBFA1. In a reporter lacZ gene, Cbfa1 expression was docusummary, these data identified the lack of expression mented at 9.5 days postcoitum (dpc) only in the notoof one allele of the CBFA1 gene as the basis of the CCD chord, at 10.5 dpc in mesoderm destined to become syndrome in humans, fully consistent with the phenobone, at 11.5 dpc in maxillary and mandibular compotype of the Cbfa1 ϩ/Ϫ heterozygous mice. The only differnents of the first branchial arch as well as humerus, at ence between the two species is the supernumerary 12.5 dpc in ribs and vertebral bodies, in the developing teeth in humans, the basis of which remains to be deterbones of limbs and pelvic girdles, as well as in jaw and mined. skull, thus corresponding closely to the earliest times CBFA1 Stimulates Osteoblast-Specific and sites of osteogenesis. These authors also observed Gene Expression an increase in nucleated hematopoietic cells in the circu-
The data reviewed so far strongly indicate that CBFA1 lation and no abnormality in thymus development. Taken plays a role in bone formation and, more specifically, in together, these findings document by several methods osteoblast differentiation. Its structure and role in other the absence of osteogenesis in Cbfa1-deficient mice systems suggest that it acts as a transcription factor. and point to a role for this transcription factor at a stage Direct evidence to that effect is provided by the fourth that precedes the expression of one of the earlier osteostudy in this series by Ducy et al. (1997 [ BMPs have been reported to induce the osteoblastic phenotype in certain cell types, such as C3H10T1/2 cells. BMP7 induced Cbfa1 expression in these cells, followed by the expression of osteocalcin and osteopontin. In addition, 1,25(OH)2D3, previously shown to suppress the mouse osteocalcin promoter, significantly reduced the expression of Cbfa1 in primary mouse osteoblastic cells.
The ultimate test for the role of Cbfa1 as a crucial nonosteoblastic or pre-osteoblastic cells. In calvariaderived nondifferentiated mouse MC3T3E-1 cells, tranbest characterized ''bone-specific'' gene. Investigation sient transfection with a CMV promoter-driven Cbfa1 of osteoblast-specific cis-acting elements identified construct significantly up-regulated expression of ␣1(I) unique regulatory DNA sequences in rat or mouse osteocollagen, osteopontin, and osteocalcin. Similar effects calcin promoters, including homeodomain-containing were observed in the nonosteoblastic C3H10T1/2 cells protein binding sites and an E-box. One of these cisand in skin fibroblasts. In the osteoblastic ROS 17/2.8 acting elements present in mouse and rat osteocalcin cells, Cbfa1 antisense mRNA down-regulated the expromoters, called OSE2, was previously shown to confer pression of ␣1(I) collagen and osteopontin, suggesting activity in osteoblasts to a heterologous promoter and to a need for its constitutive expression in mature osteobind a factor present only in osteoblast nuclear extracts blastic cells. . This factor is immunologiThis study by Ducy et al., which started with a different cally related to CBFA transcription factors (Geoffroy et and more direct approach, documents the function of al., 1995; Merriman et al., 1995) . Based on this observaCbfa1 as a transcription factor that up-regulates the tion, Ducy et al. (1997) cloned by low stringency hybridexpression of osteoblast-related genes. Its conclusions ization CBFA-like molecules from a mouse osteoblast are now strongly supported by loss-of-function evicDNA library and isolated Cbfa1, which they named Osf2 dence presented in the three other related studies in (osteoblast-specific transcription factor). By Northern this issue. analysis, Cbfa1 mRNA was expressed in bone and in Together, these papers provide compelling evidence osteoblasts, where it was 20 times more abundant than that Cbfa1 is an essential transcription factor required in T lymphocytes. Histidine-tagged recombinant Cbfa1/ for osteoblast differentiation. Osf2 protein binds to the nucleotide regulatory seOpen Questions quence of the osteocalcin promoter and coexpression By analogy to myoblast differentiation, additional tranof Cbfa1/Osf2 in C3H10T1/2 cells stimulates by 70-fold scription factors, possibly linked via regulatory feedback luciferase activity driven by six copies of the OSE2 reguloops to CBFA1, may participate in expression of CBFA1 latory sequence upstream of the osteocalcin basal proand mutually regulate each other. This is consistent with moter. This effect is abolished by a mutation in OSE2, its expression in thymocytes, liver, and testis, where it which also abolishes the binding of the Cbfa1 protein.
probably participates in the regulation of other genes. These results show that Cbfa1/Osf2 stimulates osteoIndeed, Ducy and Karsenty (1995) reported on a second blast-specific transcription of the osteocalcin gene via regulatory region in the osteocalcin promoter, and differthe OSE2 sequence. ent transcription factors that confer bone-specific ex-CBFA1 Is a Transcription Activator pression to the ␣1 promoter of type I collagen, via a of Osteoblast Differentiation distinct cis-acting element, were also recently reported Consistent with the observations reviewed above, Ducy (Rossert et al., 1996 (Rossert et al., ). et al. (1997 showed that in mouse development, expres-
The studies presented here deal with very early osteosion of Cbfa1 mRNA, examined by in situ hybridization, blast differentiation during embryogenesis, presumably is present in mesenchymal condensation at 12.5 dpc from a multipotent mesenchymal cell. Bone formation and at other sites prior to osteogenesis and osteocalcin in humans and other vertebrates occurs throughout life expression. At 16 dpc, very strong expression was seen as part of continuous skeletal remodeling and occasionin facial bones and the bones of the skull, as well as in ally during fracture repair. The two processes differ from the manubrium sternae, the sternebrae, and the hyoid each other. Fracture repair usually recapitulates the probone. No expression was detectable in chondrocytes.
cess of endochondral bone formation, whereas remodThis in vivo expression of Cbfa1 suggests that Cbfa1 eling recruits osteoblastic cells from a pool of committed may regulate expression of early markers for osteoblast cells present in the bone marrow. It is of interest if the cells participating in each of these processes express differentiation, as well as expression of osteocalcin, a CBFA1, if they express it constitutively, or if it is induced prior to osteoblastic differentiation by BMP or other factors, as observed during embryonic osteogenesis. In other words, in the terminology of developmental biology: what is the relationship of CBFA1 to osteoblast commitment and to sustained phenotype expression? Last but not least: how is the expression of CBFA1 regulated, could it be pharmacologically controlled to stimulate bone formation therapeutically, for example in osteoporosis?
In conclusion, following the myogenic and adipogenic systems, we now have the beginning of significant molecular insights into the differentiation of the osteogenic lineage (See Figure 1) . Interestingly, each of these three mesenchyme-derived cells are induced by transcription factors belonging to completely different families, HLH proteins, a nuclear receptor, and now a core binding factor; family relations can be complicated but can be resolved if patiently pursued.
